Investor Relations

Latest News

Sep 18, 2020

MPX International Increases Size of Non-Brokered Private Placement Offering to C$6,800,000

View Press Release

Aug 27, 2020

MPX International Announces Delayed Filing of Interim Financial Statements Pursuant to OSC Blanket Instrument 51-505

Aug 13, 2020

MPX International’s Wholly-Owned Subsidiary, Canveda Inc., Enters Into an Agreement for the Manufacturing and Distribution of Cannabis Products in Israel

View All News

Investor Presentation

View Presentation

Fourth Quarter 2019 Earnings Conference Call

Jan 29, 2020 • 8:30 am EDT

View Event View All

Company Overview

MPX International Corporation is focused on developing and operating assets across the global cannabis industry with an emphasis on cultivating, manufacturing and marketing products which include cannabinoids as their primary active ingredient.

View Management Team View Board of Directors

Investor Contact Information

Company

MPX International Corporation
5255 Yonge Street
Suite 701
Toronto, ON M2N 6P4
Canada
T: 416-840-3725
info@mpxinternationalcorp.com